AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,596 Increased By 136 (0.53%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)

firdous-ashiq-awanISLAMABAD: Federal Minister for National Regulation and Services Dr. Firdous Ashiq Awan here on Sunday said that a fast track plan of action had been introduced by the Drug Regulation Authority (DRA) for registration of 14,000 pending drugs at the earliest.

 

Elaborating details of the policy, Dr. Firdous said that those pharmaceutical companies, who wanted to register their drugs at the earliest, could pay double or triple fee for the purpose.

 

"We have taken this step to generate resources for the authority and also clear the backlog of 14,000 pending drug registration applications with the cooperation of pharmaceutical companies", the minister stated.

 

She said the newly established Drug Regulatory Authority was an autonomous body which was facing a number of problems, including financial constraints and pressure for registration of drugs so the new strategy had been established with the consensus of all the departments concerned.

 

She said that the policy board had finalized appointment criteria of Chief Executive Officer of the authority and it was their utmost endeavour to select a qualified, competent, professional and committed person for this seat before the expiry of their tenure.

 

"It is imperative to appoint a most suitable, competent, committed, professional and dedicated person on this seat as medicines are basic requirement of masses and our focus is to facilitate people at their doorsteps", she added.

 

He said the prime responsibility of the authority was to address the issues of pricing, quality and distribution of medicines across the country as the government was committed to provide safe, effective, quality and economically affordable drugs and medicines to the people.

 

In order to make an effective authority the minister highlighted that new section including information technology, alternate medicine finance legal and controlled drugs had been created to meet international commitments, enhanced coordination and to bring harmony in interprovincial trade and commerce of therapeutic goods.

 

Copyright APP (Associated Press of Pakistan), 2013

Comments

Comments are closed.